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Perforated small intestine in a patient with T-cell
lymphoma; a rare cause of peritonitis
1,2
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Abstract

The nontraumatic perforations of the small intestine are pathological entities with particular
aspects in respect to diagnosis and treatment. These peculiarities derive from the nonspecific clinical
expression of the peritonitis syndrome, and from the multitude of causes that might be the primary
sources of the perforation: foreign bodies, inflammatory diseases, tumors, infectious diseases, etc.
Accordingly, in most cases intestinal perforation is discovered only by laparotomy and the definitive
diagnosis is available only after histopathologic examination. Small bowel malignancies are rare;
among them, lymphomas rank third in frequency, being mostly B-cell non Hodgkin lymphomas.
Only 10% of non-Hodgkin lymphomas are with T-cell.
We report the case of a 57 years’ old woman with intestinal T-cell lymphoma, whose first
clinical symptomatology was related to a complication represented by perforation of the small
intestine. Laparotomy performed in emergency identified an ulcerative lesion with perforation in the
jejunum, which required segmental enterectomy with anastomosis. The nonspecific clinical
manifestations of intestinal lymphomas make from diagnosis a difficult procedure. Due to the fact
that surgery does not have a definite place in the treatment of the small intestinal lymphomas (for
cases complicated with perforation), and beyond the morbidity associated with the surgery performed
in emergency conditions, prognosis of these patients is finally given by the possibility to control the
systemic disease through adjuvant therapy.
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Introduction

The diagnosis becomes a challenging task

The nontraumatic perforation of the small
intestine is a rare pathological entity, which has
particular aspects in respect to the clinical
diagnosis and subsequent therapeutic conduct.
These peculiarities derive especially from the
difficulty of the preoperative diagnosis. In the
majority of cases, the peritonitis syndrome imposes
laparotomy which reveals the perforation of the
intestine.

has no significant medical history, so that the
diagnosis can be established only after surgery.
Malignant tumors of the small intestine are in
general

rare

(about

3%

among

digestive

neoplasms, and 0.5% within all cancers), having
poor clinical expression and a relatively difficult
diagnosis with usual investigative methods (5).
Regarding their histology in last decades one

In addition, there are multitude of causes that
might be the primary sources of the perforation:
foreign bodies, inflammatory diseases, tumors,
infectious

especially in circumstances in which the patient

diseases,

etc.,

so

that

only the

histopathologic examination would be conclusive
for the establishment of a definitive therapeutic

can see a reversal of proportions in incidence of
carcinoids as against adenocarcinomas while
lymphomas ranks third in frequency after these
with 17% of all malignant intestinal tumors (6).
Non-Hodgkin's lymphomas are a heterogeneous
group of neoplasms that can arise from B or T
cells, progenitors or mature, or rarely from natural

approach.

killer cells. 10 to 30 percent of patients with NHL
A variable geographical distribution can be have extra-nodal disease (7).The digestive tract
observed when considering the etiology and represents the most frequent location of the nonincidence on age groups of the small intestine’s Hodgkin extra-nodal lymphoma, about 36%,
perforations. The infectious causes, such as affecting the stomach, small intestine and colon, in
typhoid fever or tuberculosis predominate in order of frequency (8).
tropical areas and in the developing countries,
being often found at young aged patients, 20-30
years old, as opposed to the western countries Case report
where these cases appear much rarer and to older
age

groups,

having

inflammatory

diseases,

as

possible

tumors,

causes

radiotherapy,

We report the case of a 57 years’ old woman,
with no significant medical history, admitted to the
hospital for intense and diffuse abdominal pain,

ingestion of foreign bodies or circulatory disorders
(1- 4).

which emerged around 3 hour prior to the arrival at
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the hospital. The patient described the debut of the situated at the anti-mesenteric border on a jejunum
pain in the upper abdomen, all of a sudden, like a loop about 60 cm from the Treitz angle (Figure 1).
„stubbing” feeling followed soon by the extending
to the entire abdominal area.
Physical examination reveals fever 380C,
tachycardia

and

abdominal

distention

with

tenderness to palpation and absence of bowel
sounds.
Laboratory tests showed normal values for
leucocytes (WBC- 8250 /µL), neutrophil count not
Figure 1.

elevated (NEU- 6260/ µL), low values for
lymphocyte count(LYM- 1170/µL/ 14,22%), red
blood cells (RBC) 3,62 /*10^6 µL, Hemoglobin
(Hb) 10.2g/dL and HTC31,9%. It was also found
decreased levels for sodium (130,5mmol/L) and
potassium 3,23mmol/L. No other changes were
found in laboratory tests on admission.

The perforation adjacent area had a pale
appearance and the mesentery exhibited multiple
enlarged lymph nodes which were conglomerated
especially at the root of the mesentery forming
large lymphadenopathy masses at this level. The
other intraperitoneal organs including liver and

Plain X-ray film of the abdomen in upright spleen had no changes macroscopically.
position showed the presence of free air under the

Small bowel resection and widely excision of

left diaphragm. Chest radiography did not identify adjacent mesentery was performed (Figure 2). The
changes in lungs or mediastinum.
clinical,

imaging

presumptive

and

diagnosis

Based

laboratory
was

on continuity was restored by end to end suturing

data

peritonitis

the anastomosis. Postoperative evolution was simple
from with no complications, and the patient was

perforated viscera and laparotomy was decided.

discharged 7 days after surgery.

Midline vertical incision was made. The
opening of the peritoneal cavity revealed small
bowel content in peritoneum (succus entericus) about

Histopathological examination revealed:
Intestinal wall presenting a large ulceration
1,5cm

with

perforation

and

diffuse

and exploration showed a 3 millimeters perforation transmural infiltration with large discoid cells
90
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presenting

oval

and

vesicular

nuclei

and

eosinophilic cytoplasm in reduced amount; large
number of areas of granulomatous inflammation.
Multiple tumor cells with hyperchromic and
hypertrophic nuclei; tumoral cells with multiple
nuclei

and

atypical

mitosis.

Mesenteric

lymphnodes exhibited an altered architecture with
sinusal

hystiocytosis

and

irregular

germinal

centers. This appearance was suggestive of diffuse

Figure 2.

large cells intestinal lymphoma.
Immunohistochemical examination revealed:

Discussion
The primitive lymphomas of digestive tract

CD3 diffuse positive in tumoral cells, CD2
positive in tumoral cells, CD 25 positive in rare
tumoral cells, CD5 negative in tumoral cells, CD30
diffusely positive in tumoral cells cytoplasm and
intense positive in some membranes; CD15
positive in numerous granulocytes and in rare
tumoral cells with granule appearance near the
nuclei; CD20 and CD79a negative in tumoral cells;

aspect

decades a slight increase of their incidence (with
percentage between 3 and 5) is reported. It is
possible that this growth is due to the improvement
of

the immunohistochemical

diagnosis

which

facilitates their diagnosis (8, 9).
The cellular tissue from which these
malignancies arise is represented by the MALT

ALK negative in tumoral cells.
Histopathological

remain rare entities, even though in the last

and

immuno-

histochemically tests are compatible with the
diagnosis of Malign non Hodgkin lymphoma with
T-cell type anaplastic large T-cell lymphoma ALK
negative (ALCL, ALK ). Testing for hepatitis B,
hepatitis C and HIV serology were negative using
the western blotting procedure, and absence of the
specific anti-HTLV I/II antibodies was confirmed.

(mucosa associated lymphoid tissue), designating a
heterogeneous

population

of

cells

with

immunologic role quartered at the level of
digestive tract mucosa, playing an essential role as
a protection barrier of body from a large variety of
antigens.
The intestine hosts the lymphoid tissue in
follicles, in Peyer’s plaques, in lamina propria and

Nontraumatic perforations of the small intestine

intraepithelial and the mesenteric lymph nodes

Considering frequency order criteria, these

make connection to the peripheral immune system.

locate predominant at stomach level, which sums
50-60% from primary digestive tract lymphomas;

The variety of the enteral lymphoid tissue’s 20-50% affect the small intestine, especially the
cells is very wide, but each phenotype can be ileum. Very seldom, the primitive lymphomas can
individualized

with

cytogenetic

and be found at the colon and rectum level (14- 17).

immunohistochemical techniques, so allowing the

The symptoms

are

uncharacteristic for

anatomo-clinical framing of the lymphomas, the intestinal lymphomas, for example abdominal
indication of the treatment and the prognostic bloating and distension, colic abdominal pain, loss
assessment.

of appetite, nausea or may have the clinical

Almost

90%

of

the

gastrointestinal

lymphomas derive from B lymphocytes and very
few from T lymphocytes (10). They can be
classified

into

three

immunoproliferative

small

main

categories:

intestinal

expression

of

an

acute

complication

like

perforation, occlusion or bleeding. Other general
signs also nonspecific are so called B symptoms
(fever, weight loss and night sweats) which
occurring in the context of a lymphoma get a

disease prognosis value (18).

(IPSID), enteropathy-associated T cell lymphoma
Classical methods of imaging diagnosis (EATL) which arises mostly in gluten-sensitive
enteropathy and a third category comprising
diffuse large B cell lymphoma, mantle cell
lymphoma, Burkitt lymphoma and follicular
lymphoma (11).

barium studies and CT – can reveal tumors as
intra- or extraluminal masses, polyps or parietal
infiltration areas without offering data regarding
the type of the lesion. On the other hand,
endoscopy and particularly the “push and pull

What causes for lymphomas is still unknown, technique” with double balloon enteroscopy allows
but a set of conditions seem to favor their both biopsy sampling as well as execution of
development:

bacterial

infections

(e.g. therapeutic maneuvers (19, 20).

Helicobacter pylori or Helicobacter heilmannii),

The gastrointestinal localization can be

viruses (HTLV-1 in human T-cell lymphoma virus, secondary in non-Hodgkin lymphomas, appearing
Epstein-Barr

in

Burkitt

lymphoma),

severe most frequently in the context of a widespread

immune deficiencies (AIDS, Waldmann disease) nodal disease and much rarely as a primary
or celiac disease (8, 12, 13).

location.

92
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In order to decide a diagnose to this last form in this way to offer the therapist an easier and more
it is necessary for the lesion to be limited to the complex working instrument (24).
intestine’s level, the spleen and the liver not to be
affected,

no mediastinal and peripheral lymph-

WHO (World Health Organization) scheme
is the general frame of classification of lymphoid

adenopathy must be present, and the number of
neoplasms

unanimously

accepted,

wherewith

white blood cell count must be in normal limits
different categories of diseases are defined by
(21, 22, 23).
multidisciplinary
The

digestive

lymphomas

evaluation

approach

including

clinical,

genetic, phenotypic and histological features (25).

presumes a general balance that compulsory
includes the exploration of renal function, hepatic

The latter two classifications – TNM staging

function, serum electrolytes, blood test, lactic system and WHO scheme–meet the broadest
dehydrogenase, uric acid, chest x-ray, glycaemia consensus

use

for

primary

gastrointestinal

and bone marrow biopsy. The evaluation is lymphomas.
completed with the CT exam of the thorax,

The gastrointestinal lymphomas treatment is

abdomen and pelvis. The anamnestic data and the
complete physical exam can suggest particular
etiologies that can be confirmed by specific

multimodal

and

correlative

with

the

histopathological type and the stage of the disease.
Taking into consideration the large variety in

investigations.

lymphomas types, the therapeutically arsenal is
There is still not a consensus regarding the
staging

system

for

primary

gastrointestinal

lymphomas. The classical systems such as type

complex too, but adaptable concurrently with a
better understanding of pathogenesis and the

Ann Arbor or Lugano seem to lend less, by molecular biology’s progress (26).
omitting the disseminated forms or overlapping
some distinctive clinical forms.

The

Helicobacter

pylori

infection

is

considered to be a predisposing factor to the

The Paris staging resorts to TNM type development

of

the

gastrointestinal

tract

classification through which one can assess the lymphomas, even though it does not associate with
degree of the tumor extends in the depth of the a histopathological distinct type of these. The
digestive wall, the contiguous lymph nodes bacteria eradication treatment is part of the gastric
involvement and the specific spread, contributing lymphomas therapeutic strategies (27, 28).

Nontraumatic perforations of the small intestine

The chemotherapy is administrated in cycles perforations occur in the first 4-5 weeks of
having types of cyclophosphamide-doxorubicin- chemotherapy (34, 35).
vincristine combinations, or cyclophosphamidevincristine to which it can be added prednisone or
rituximab (29).

Intraoperative appearance can be often in the
form

of

an

macroscopically

ulceration

which

indistinguishable

can

from

be
other

Radiotherapy finds its utility in forms forms, and in this situation the histopathology
localized at stomach, duodenum or rectum level, examination becomes decisive in the establishment
but enteral lymphomas may have less benefit from of the lesion’s nature especially when the
it taking into account that they are often multifocal perforation appears in a case of a patient with no
relevant case history.

(30, 31).
Only low-grade B-cell lymphoma of the

In order to define the prognosis of these

small intestine can benefit from surgical resection patients, several factors were taken into account
as unique therapeutic method. In all the other but a real clinical significance have proved to have
cases, the role of surgery remains disputable, even histological B type, symptoms, therapeutic
though some studies show better survival rates of modality, original site, LDH level and
patients that were both having surgeries and complication occurrences.
following chemotherapy treatment, as compared to

Worst prognosis is associated with high-

the ones who only had chemotherapy. The small grade lymphoma and intestinal location (36).
number of patients included in these studies does
According to other studies, even though the
not

allow

the

establishment

of

definitive
perforation is a life-threatening complication, it

conclusions and the imposition of guidelines (32,
seems to not influence the final prognostic of these
33).
subjects, which is ultimately given by the
Complications of gastrointestinal lymphomas possibility to control the main disease (34).
are represented by obstruction, hemorrhage and
perforation. For the small bowel as a particular
location of lymphomas, perforation occurs in 9%
of cases and it is associated with aggressive forms

Conclusions
Primitive

gastrointestinal

lymphomas

of the disease and chemotherapy. More than half of represent a rare pathological entity and among
94

Banu P. et al.

these, only 10% are T-cell type. The absence of 3. Leijonmarck

CE,

Fenyo

G,

Raf

L.

specific signs and symptoms makes clinical

Nontraumatic perforation of the small intestine.

diagnosis to be particularly difficult for these ones.

ActaChirScand 1984;150: 405–411.

These

malignancies

benefit

from

a 4. Kimchi NA, Broide E, Shapiro M, Scapa E.

multimodal treatment in which surgery has not yet

Non-traumatic

a definitive place. The role of surgery in the

intestine. Report of 13 cases and review of the

treatment of GI lymphomas remains a topic in
debate and in literature has conflicting data

perforation

of

the

small

literature. Hepato-Gastroenterology 2002; 49:
1017–22.

regarding the therapeutic benefit of the surgical
act. This is largely a consequence of the small

5. Siegel RL, Miller KD, Jemal A. Cancer

number of cases included in reports so that clear

statistics, 2015. CA Cancer J Clin. 2015; 65(1):

guidelines cannot be traced yet.

5-29.

The occurrence of a complication such as 6. Bilimoria KY, Bentrem DJ, Wayne JD, Ko
perforation compels emergency surgical treatment

CY, Bennett CL, TalamontiMS. Small bowel

and lesion’s resolving. Although perforation is a

cancer in the United States: changes in

life threatening complication and beyond the

epidemiology, treatment, and survival over the

morbidity of the surgical acts itself, the prognosis

last 20 years. Ann Surg. 2009; 249(1): 63-71.

of these patients eventually is given by the ability 7. Anderson T, Chabner BA, Young RC, Berard
to control the underlying disease.

CW, Garvin AJ, Simon RM, DeVita VT Jr.
Malignant lymphoma. 1. The histology and
staging of 473 patients at the National Cancer
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